US agencies not understand the hydroxychloroquine benefits
Donald Trump’s remarks came hours after the US Food and Drug Administration revoked its Emergency Use Authority for hydroxychloroquine to treat COVID-19.
The US Food and Drug Administration on Monday revoked the authorization of its emergency use for hydroxychloroquine for the treatment of COVID-19, but quickly came under fire from US President Donald Trump, who said only U.S. agencies fighting coronaviruses I fail to understand its benefits.
Based on new evidence, the FDA stated that it was no longer reasonable to believe that hydroxychloroquine and the related drug chloroquine could be effective in treating novel coronavirus-caused illness.
The FDA also warned that drugs have been shown in lab studies to interfere with Gilead Sciences Inc.’s antiviral drug remediesvir – the only one yet to show benefit against COVID-19 in formal clinical trials It is a medicine.
The move comes after several studies of decades-old malaria pills stated that they were not effective as a treatment or to prevent COVID-19.
A major trial was halted after British scientists decided earlier this month that hydroxychloroquine was “useless” in treating COVID-19 patients.
US President Donald Trump said that other countries had provided great reports on hydroxychloroquine.
Initial enthusiasm was partly based on laboratory experiments in which the drug appeared to neutralize the virus. Chloroquine, which has not been approved for any use in the United States and has more side effects, has not performed any better in human clinical trials.
In March, Trump said that hydroxychloroquine in combination with the antibiotic azithromycin had “a real chance of being one of the biggest game changers in the history of the drug”, with little evidence to support this claim.
He later stated that he stopped the drugs immediately after diagnosing two people working at the White House with COVID-19, and urged others to try it.
Trump said on Monday, “I took it and I felt good about taking it. I don’t know if it had any effect, but it didn’t hurt me.”
Trump said there were “great reports” from France, Spain and other places, with no evidence or further explanation. France is one of the countries that has already stopped using the drug for COVID-19 patients.
US Health and Human Services Secretary Alex Azar said the drug is being studied for possible use in the first phase of the disease.
“A lot of the figures that have come out were more negative, people who were quite ill in hospital,” he said.
The drug can still be used with a prescription, Azar said. Any drug with US approval can be used in any way the doctor sees fit, even if it is prescribed.